G9071 Onc diagnosis brst stg1-2b hr,nopro
G-Codes
Also known as: hormone-positive breast cancer early, HR+ breast cancer stage 1-2
Performance measure documenting breast cancer stage 1-2B, hormone receptor positive, without evidence of disease progression.
Clinical Context
Quality measure documenting early-stage hormone receptor-positive breast cancer for endocrine therapy planning.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.